Telmisartan alters the transcriptomes of cancer associated fibroblasts and fibrocytes in a solid tumour model
Cancer associated fibroblasts (CAFs) are the main contributors to fibrosis in solid tumours. Fibrosis can lead to increased tumoural stiffness, immune cell exclusion, and poor response to cancer therapies. However, therapeutically depleting CAFs has been shown to increase tumour progression and metastasis in some pre-clinical tumour models. Targeted approaches to inhibit CAF activity and decrease…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
